Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria reductions and eGFR stabilization with povetacicept in patients with IgA ...

The Qualcomm Snapdragon X2 Elite improves upon its predecessor in almost every way, with improved performance and efficiency ...

In today’s data-driven economy, reliability is the true differentiator. It’s no longer enough to deliver data; we must ...

B&W projects full year 2026 adjusted EBITDA in the range of $70 million to $85 million from its core business, a figure that does not include potential upside from AI data center projects. Young ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

Wagner announced, "We now expect 2025 total revenue to be in a range of $11.9 billion to $12 billion versus prior guidance of $11.85 billion to $12 billion, representing growth of approximately 8% to ...

There is a lot of enterprise data trapped in PDF documents. To be sure, gen AI tools have been able to ingest and analyze PDFs, but accuracy, time and cost have been less than ideal. New technology ...

- Vertex on track to initiate rolling submission of Biologics License Application for potential accelerated approval to the U.S. Food and Drug Administration this year; full enrollment completed for ...

- 48-week data show a 64% decrease from baseline in proteinuria in IgA nephropathy, 82% decrease from baseline in proteinuria in primary membranous nephropathy, and stabilization of estimated ...

TEL AVIV, Israel, Nov. 3, 2025 /PRNewswire/ -- Incredibuild, a leader in build acceleration and intelligence, today announced the acquisition of Kypso, a startup building AI agents for engineering ...